Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,772,974
  • Shares Outstanding, K 237,664
  • Annual Sales, $ 44,580 K
  • Annual Income, $ -328,070 K
  • 60-Month Beta 0.83
  • Price/Sales 39.99
  • Price/Cash Flow N/A
  • Price/Book 4.44
Trade RXRX with:

Options Overview Details

View History
  • Implied Volatility 78.00% ( +0.44%)
  • Historical Volatility 73.59%
  • IV Percentile 17%
  • IV Rank 29.04%
  • IV High 160.69% on 07/12/23
  • IV Low 44.15% on 10/03/23
  • Put/Call Vol Ratio 0.33
  • Today's Volume 4,119
  • Volume Avg (30-Day) 5,187
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 106,651
  • Open Int (30-Day) 100,018

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.35
  • Low Estimate -0.41
  • Prior Year -0.38
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.75 +6.07%
on 06/27/24
9.99 -28.33%
on 06/18/24
-1.12 (-13.53%)
since 05/31/24
3-Month
6.75 +6.07%
on 06/27/24
10.66 -32.86%
on 05/15/24
-1.61 (-18.36%)
since 04/02/24
52-Week
4.97 +44.06%
on 11/01/23
16.75 -57.24%
on 07/19/23
-0.31 (-4.15%)
since 06/30/23

Most Recent Stories

More News
3 Small-Cap Stocks Set To Skyrocket

These under-the-radar companies may offer greater long-term rewards.

NVDA : 122.67 (-1.31%)
MSFT : 459.28 (+0.56%)
RXRX : 7.16 (-4.02%)
$SPX : 5,509.01 (+0.62%)
ARDX : 5.28 (-30.25%)
MGNI : 13.49 (-0.30%)
NFLX : 679.58 (+0.89%)
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim

The CEO has set a high bar for the business, and if it hits it, the stock could easily 10x in value.

NVDA : 122.67 (-1.31%)
RXRX : 7.16 (-4.02%)
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider

Both of these companies could soon set the standard in their fields.

LLY : 906.71 (-0.84%)
VKTX : 51.54 (-6.83%)
RXRX : 7.16 (-4.02%)
Cathie Wood Owns These 2 AI Stocks. Should You?

One looks like a solid option. The other one, not so much.

NVDA : 122.67 (-1.31%)
META : 509.50 (+0.96%)
RXRX : 7.16 (-4.02%)
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?

Recursion Pharmaceuticals hopes to transform the healthcare industry with the help of AI.

NVDA : 122.67 (-1.31%)
RXRX : 7.16 (-4.02%)
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk

You don't need to buy her picks, but it's worth understanding them.

RHHBY : 34.4300 (-0.61%)
ARKK : 44.82 (+0.83%)
ARKG : 22.89 (-1.46%)
DNA : 0.3465 (+7.21%)
RXRX : 7.16 (-4.02%)
2 Stocks That Could 10x by 2035

These stocks are very promising, but it's important to consider the downside, too.

LLY : 906.71 (-0.84%)
VKTX : 51.54 (-6.83%)
RXRX : 7.16 (-4.02%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

RXRX : 7.16 (-4.02%)
SDGR : 20.33 (+8.37%)
EXAI : 5.10 (-0.97%)
NVDA : 122.67 (-1.31%)
What's the Difference Between Biotech Stocks and TechBio Stocks?

A few enterprising businesses are marketing themselves differently.

DNA : 0.3465 (+7.21%)
RXRX : 7.16 (-4.02%)
SDGR : 20.33 (+8.37%)
Cathie Wood Is Buying This Under-the-Radar AI Stock

This company has massive upside potential, but that's not the whole story.

NVDA : 122.67 (-1.31%)
RXRX : 7.16 (-4.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

See More

Key Turning Points

3rd Resistance Point 7.78
2nd Resistance Point 7.61
1st Resistance Point 7.38
Last Price 7.16
1st Support Level 6.99
2nd Support Level 6.82
3rd Support Level 6.59

See More

52-Week High 16.75
Fibonacci 61.8% 12.25
Fibonacci 50% 10.86
Fibonacci 38.2% 9.47
Last Price 7.16
52-Week Low 4.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar